Skip to content

Randomized, Blind, Parallel Controlled, Noninferiority Clinical Trial to Evaluate Safety and Effectiveness of Upper Limb Rehabilitation Robot

The effect of upper limb robot in stroke

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044078
Enrollment
Unknown
Registered
2021-03-09
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Sponsors

Department of Rehabilitation Medicine of Tongji Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) 18-70 years old, male or female; 2) The first stroke was clearly diagnosed on the imaging of symptoms and signs; 3) Patients with upper limb motor dysfunction, with Fugl-Meyer upper limb motor function score between 8 and 38; 4) Stable vital signs for more than 48 hours; 5) The patient has certain cognitive learning ability and can realize human-computer interaction; 6) The patient can maintain the sitting position for 45min each time; 7) Sign the informed consent and participate in the study voluntarily.

Exclusion criteria

Exclusion criteria: 1) History of stroke; 2) Excessive spasm of upper extremity, modified Ashworth grade 3 or above; 3) Other conditions that significantly affect the patient's upper limb function, such as: joint muscle contracture, severe freezing, shoulder arthritis, skin ulcer, pressure ulcer, recent surgical incision or active skin disease; 4) Possess cardiac pacemakers or other implanted electronic devices; 5) People with severe cognitive impairment and inability to effectively communicate with medical staff; 6) People with orthopedic surgery rheumatism or other diseases that limit upper limb movement; 7) Participated in other clinical trials within 90 days; 8) Other circumstances considered inappropriate by the researcher to participate in the study.

Design outcomes

Primary

MeasureTime frame
Fugl-meyer;

Secondary

MeasureTime frame
MBI;WHO DAS 2.0;kinematic assessment of IMU;EMG;TMS;fMRI;

Countries

China

Contacts

Public ContactXiaolin Huang

Tongji Hospital of Tongji Medical College of Huazhong University of Sc

xiaolinh2006@tjh.tjmu.edu.cn+86 27-83662885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026